Literature DB >> 17172475

The significance of substance P in physiological and malignant haematopoiesis.

Michal Nowicki1, Danuta Ostalska-Nowicka, Beata Kondraciuk, Bogdan Miskowiak.   

Abstract

The role of substance P (SP) in physiological haematopoiesis is well established. However, it also seems to be important in the neoplastic transformation of bone marrow, leading to the development of acute leukaemia in children, and also metastases to bone marrow of solid tumours (particularly neuroblastoma and breast cancer) in early stages of these diseases. This review summarises the available data on SP involvement in both processes. In the future, SP antagonists may be used as anti-neoplastic drugs, for example by direct or indirect blocking of tumour cell proliferation through inhibition of growth factor production and interleukin-1b synthesis.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17172475      PMCID: PMC1995773          DOI: 10.1136/jcp.2006.041475

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  101 in total

1.  Differential expression of functionally identified and immunohistochemically identified NK(1) receptors on sympathetic neurons.

Authors:  P Jobling; J P Messenger; I L Gibbins
Journal:  J Neurophysiol       Date:  2001-05       Impact factor: 2.714

Review 2.  Mesenchymal stem cells: biology and potential clinical uses.

Authors:  R J Deans; A B Moseley
Journal:  Exp Hematol       Date:  2000-08       Impact factor: 3.084

3.  Calcitonin gene-related peptide, substance P, and tyrosine hydroxylase-immunoreactive innervation of rat bone marrows: an immunohistochemical and ultrastructural investigation on possible efferent and afferent mechanisms.

Authors:  S Imai; Y Tokunaga; T Maeda; M Kikkawa; S Hukuda
Journal:  J Orthop Res       Date:  1997-01       Impact factor: 3.494

Review 4.  Regulatory mechanisms in stem cell biology.

Authors:  S J Morrison; N M Shah; D J Anderson
Journal:  Cell       Date:  1997-02-07       Impact factor: 41.582

5.  Increased expression of preprotachykinin-I and neurokinin receptors in human breast cancer cells: implications for bone marrow metastasis.

Authors:  D Singh; D D Joshi; M Hameed; J Qian; P Gascón; P B Maloof; A Mosenthal; P Rameshwar
Journal:  Proc Natl Acad Sci U S A       Date:  2000-01-04       Impact factor: 11.205

Review 6.  Mesenchymal stem cells: building blocks for molecular medicine in the 21st century.

Authors:  A I Caplan; S P Bruder
Journal:  Trends Mol Med       Date:  2001-06       Impact factor: 11.951

7.  Adrenomedullin as an autocrine/paracrine apoptosis survival factor for rat endothelial cells.

Authors:  H Kato; M Shichiri; F Marumo; Y Hirata
Journal:  Endocrinology       Date:  1997-06       Impact factor: 4.736

8.  Hemokinin is a hematopoietic-specific tachykinin that regulates B lymphopoiesis.

Authors:  Y Zhang; L Lu; C Furlonger; G E Wu; C J Paige
Journal:  Nat Immunol       Date:  2000-11       Impact factor: 25.606

9.  Substance P enhances IL-2 expression in activated human T cells.

Authors:  C F Calvo; G Chavanel; A Senik
Journal:  J Immunol       Date:  1992-06-01       Impact factor: 5.422

Review 10.  Bone marrow stromal stem cells: nature, biology, and potential applications.

Authors:  P Bianco; M Riminucci; S Gronthos; P G Robey
Journal:  Stem Cells       Date:  2001       Impact factor: 6.277

View more
  16 in total

Review 1.  Neural regulation of hematopoiesis, inflammation, and cancer.

Authors:  Maher Hanoun; Maria Maryanovich; Anna Arnal-Estapé; Paul S Frenette
Journal:  Neuron       Date:  2015-04-22       Impact factor: 17.173

2.  Tachykinins and Neurokinin Receptors in Bone Marrow Functions: Neural-Hematopoietic Link.

Authors:  Tilman E Klassert; Shyam A Patel; Pranela Rameshwar
Journal:  J Receptor Ligand Channel Res       Date:  2010-04-01

Review 3.  The peptide network regulated by angiotensin converting enzyme (ACE) in hematopoiesis.

Authors:  Xiao Z Shen; Kenneth E Bernstein
Journal:  Cell Cycle       Date:  2011-05-01       Impact factor: 4.534

Review 4.  Neural Regulation of Bone and Bone Marrow.

Authors:  Maria Maryanovich; Shoichiro Takeishi; Paul S Frenette
Journal:  Cold Spring Harb Perspect Med       Date:  2018-09-04       Impact factor: 6.915

Review 5.  Lymphatic system: a vital link between metabolic syndrome and inflammation.

Authors:  Sanjukta Chakraborty; Scott Zawieja; Wei Wang; David C Zawieja; Mariappan Muthuchamy
Journal:  Ann N Y Acad Sci       Date:  2010-10       Impact factor: 5.691

Review 6.  Targeting stem cell niches and trafficking for cardiovascular therapy.

Authors:  Nicolle Kränkel; Gaia Spinetti; Silvia Amadesi; Paolo Madeddu
Journal:  Pharmacol Ther       Date:  2010-10-20       Impact factor: 12.310

7.  Angiotensin-converting enzyme is required for normal myelopoiesis.

Authors:  Chentao Lin; Vivekanand Datta; Derick Okwan-Duodu; Xu Chen; Sebastien Fuchs; Randa Alsabeh; Sandrine Billet; Kenneth E Bernstein; Xiao Z Shen
Journal:  FASEB J       Date:  2010-12-09       Impact factor: 5.191

8.  Human acute myeloid leukemia cells express Neurokinin-1 receptor, which is involved in the antileukemic effect of Neurokinin-1 receptor antagonists.

Authors:  A Molinos-Quintana; P Trujillo-Hacha; J I Piruat; J A Bejarano-García; E García-Guerrero; J A Pérez-Simón; Miguel Muñoz
Journal:  Invest New Drugs       Date:  2018-05-02       Impact factor: 3.850

9.  Neurotrophins regulate bone marrow stromal cell IL-6 expression through the MAPK pathway.

Authors:  Fariba Rezaee; Stephanie L Rellick; Giovanni Piedimonte; Stephen M Akers; Heather A O'Leary; Karen Martin; Michael D Craig; Laura F Gibson
Journal:  PLoS One       Date:  2010-03-15       Impact factor: 3.240

10.  Evaluation of serum level of substance P and tissue distribution of NK-1 receptor in breast cancer.

Authors:  Monireh Davoodian; Nadia Boroumand; Mostafa Mehrabi Bahar; Amir Hosein Jafarian; Mahdi Asadi; Seyed Isaac Hashemy
Journal:  Mol Biol Rep       Date:  2019-01-25       Impact factor: 2.316

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.